Novartis Stops Drug Marketing Amid Safety Concerns
Nudged by the U.S. Food and Drug Administration, Switzerland's Novartis on Friday agreed to stop marketing the drug Zelnorm amid concerns the drug could trigger serious heart problems....To view the full article, register now.
Already a subscriber? Click here to view full article